New tool serves as a resource for novel TB diagnostics
The TB Diagnostics Pathway is a virtual management tool that documents the progress of TB diagnostics and adjunct innovations from development to roll-out. Developed in collaboration with the Stop TB Partnership, the McGill International Tuberculosis Centre, Unitaid, the World Health Organization and other partners, the framework supports diagnostic innovators as well as country representatives, policy makers and community advocates.
The Pathway details ten key stages for TB diagnostics, spanning development, commercialization, rollout and implementation. The online interface draws from case studies and interviews to identify key stakeholders, resources, insights and critical barriers for rapid introduction and widespread scale-up of novel technologies, as well as ways to mitigate them.
The TB Diagnostics Pathway links to key materials created by FIND and partners including target product profiles for development, guidance and protocols for clinical trials, and documents used for WHO review and national approval processes. It also serves as the basis for the stages in FIND’s Diagnostic Pipeline Tracker, an interactive and dynamic website that maps the status and estimated release dates of diverse diagnostic solutions.
“We consider the TB Diagnostics Pathway and Pipeline Tracker critical support tools for developers and implementers and are pleased to make them available as prolific resources to further innovation,” said Catharina Boehme, CEO of FIND.
The participation of FIND in the development of these tools is supported by the Australian government and UK aid from the UK government.
Please find more information about FIND’s TB programme here.
Nature Microbiology piece: A web-based pathway to guide TB diagnostics innovators